Changes for page Neurodiagnoses

Last modified by manuelmenendez on 2025/03/03 22:46
From version 23.1
edited by manuelmenendez
on 2025/01/29 18:46
Change comment: There is no comment for this version
To version 26.1
edited by manuelmenendez
on 2025/01/29 18:48
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -23,9 +23,6 @@
23 23  * **Axis 2**: Molecular Markers (biomarkers).
24 24  * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
25 25  
26 -[[For instance, neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
27 -
28 -
29 29  This methodology enables:
30 30  
31 31  * Greater precision in diagnosis.
... ... @@ -36,6 +36,8 @@
36 36  
37 37  There have been described these 3 diagnostic axes:
38 38  
36 +[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
37 +
39 39  * (((
40 40  **Axis 1: Etiology**
41 41  
... ... @@ -83,6 +83,8 @@
83 83  )))
84 84  
85 85  
85 +
86 +
86 86  (% class="col-xs-12 col-sm-4" %)
87 87  (((
88 88  {{box title="**Contents**"}}